Feature|Articles|February 3, 2026
Roundup: Every Most Favored Nation Agreement With the Trump Administration
Author(s)Luke Halpern, Associate Editor
Fact checked by: Ron Panarotti
Explore all 16 agreements struck thus far between pharmaceutical companies and the White House to adhere to most favored nation pricing for drugs sold in the United States.
Advertisement
Advertisement
Most favored nation (MFN), the approach in which a country’s drugs are priced at the lowest amount comparable to that of any other developed nation, is being rapidly adopted in the United States. The White House has sought voluntary agreements with dozens of pharmaceutical companies to ensure compliance with MFN principles and attempt to lower drug prices for American consumers. These deals could turn the pharmaceutical industry on its head.
Advertisement
Advertisement
